Stability tests prompt Bausch & Lomb ReNu recall

Substandard quality identified in routine testing and reports of sensitivity have prompted to Bausch & Lomb to make a two-part precautionary recall of its ReNu contact lens solution in Europe and the Middle East.

Part one involves one lot of 120-milliliter ReNu MultiPlus multi-purpose solution. The company says it received "a small number of reports about sensitivity issues related to this lot," according to a press report. The product was distributed in Croatia, Dubai, Hungary, Slovenia, Romania, Turkey and Saudi Arabia.

In part two, Bausch & Lomb is recalling some lots of both the ReNu and ReNu MultiPlus solutions in Europe and the Middle East. "They are not meeting our quality expectations," the company said in the report. Stability monitoring showed sub-par  performance.

The recalled products show no indication of safety or efficacy issues, the company says.

- here's the article

Suggested Articles

South Korea’s Celltrion, which has a massive biologics site in Songdo, has decided it is time to build some operations in China.

WuXi Biologics is taking control of a Bayer plant in Germany and agreed it could serve as a backup facility for supply of hemophilia drug Kovaltry.

A Chinese OTC drugmaker gets the distinction of ringing in the new year as the first company to be slapped with an FDA warning letter.